Pharmetheus: Advancing model informed drug development

Demands from payors and regulators for differentiated products necessitates creative integration of available data/information, with future trial data, to accelerate drug development in an efficient, cost effective and ethical manner.
Pharmetheus
  • Has expertise in model informed drug development (MIDD) to support and inform study and program strategies and decisions.
  • Has a track record of efficient delivery of fit for purpose solutions, including complex situations.
  • Has access to a broad range of complementary drug research and development disciplines (including pharmacometrics, clinical pharmacology, statistics and regulatory) and academic subject matter experts.

Pharmetheus: transforming quality science to informed decisions

Drug development moves at a swift pace in an ever-changing competitive landscape and project teams are constantly facing new challenges, demanding a flexible proactive and adaptive mindset.
Pharmetheus
  • Offers a broad range of fit for purpose analytical solutions, including data programming, across all phases of research and development (incorporating submission and post approval activities).
  • Has a broad resource pool to accommodate varying needs, including modeling, training, interaction with regulatory bodies, expert advice and full-time equivalent support.
  • Has experience of, and expertise in, a wide range of therapeutic areas.

Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions.

Our Communications

Latest news from Pharmetheus. See our response to COVID-19

PK-Sim/MoBi workshop at the FDA

June 1, 2021

Pharmetheus is proud to have held a PK-Sim/MoBi workshop at the FDA. As members of the Open System Pharmacology Suite management team and of the scientific community, we partnered together with the University of Waterloo and Bayer AG for this event. The webinar series included sessions on 1) PK-Sim introduction, 2) Oral drug absorption, 3) Qualification Concept and Paediatric predictions, and 4) PBPK modeling of locally acting drugs.


Don’t hesitate to contact us if you’d like to hear more details on this.

Services

Our services include quantitative analyses by scientists with extensive therapeutic area experience industry, academic and regularly settings.

Our team

Pharmetheus consultants and advisors present a unique collection of experiences and combination of skill sets.
Quality Control Reviewer and Medical Writer
Senior Consultant
Service Desk Manager
Board Member
Chief Financial Officer
Principal Consultant & Chief Statistician
Associate Consultant
Principal Consultant
Senior Consultant
Consultant
Principal Consultant & Team Leader
QC and Medical Writer
Associate Consultant
Data Programmer
Board Member
Consultant & Data Protection Officer
Associate Data Programmer
Advisor
Principal Consultant, Team Leader & Board Member
Data Programmer & Team Leader
Associate Consultant
Associate Consultant
Senior Consultant, Quality Assurance Officer & Team Leader
System Administrator
Consultant
Consultant
Associate Consultant
Principal Consultant
Senior Consultant
Senior Consultant
Project Coordinator
Advisor & Chair of the Board
Analyst System Administrator
Associate Consultant & System Developer
Administrative Assistant
Principal Consultant & Team Leader
Consultant
Chief Executive Officer
Analyst QC and Medical Writer
Consultant
Principal Consultant & Team Leader
Administrative Assistant

Request our services

If you are interested in our services, please fill out the form below.

How we work

Our way of working, with traceability and accountability from data programming to report delivery, is well adapted to, and highly compatible with, current regulatory requirements.